Year-end Sale % OFF 
Abstract
Lung cancer has the highest mortality rate of all cancers worldwide. Lung squamous cell carcinoma (LSCC) comprises a large fraction of non-small cell lung cancer (NSCLC), and annually accounts for 50,000 deaths in the US. Unlike lung adenocarcinoma, there is currently no first-line targeted therapy for LSCC. The PH domain and leucine-rich repeat protein phosphatase 2 (PHLPP2) has been reported to be a potent tumor suppressor in many human cancers. However, the underlying mechanisms by which PHLPP2 exerts tumor suppressive effects have not been fully investigated.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
